期刊文献+

冠状静脉窦逆行灌注VEGF蛋白的实验研究 被引量:2

Experiment study about VEGF retrograde perfusion through coronary sinus in rabbit myocardial infarction model
下载PDF
导出
摘要 目的观察经冠状静脉窦逆行灌注血管内皮生长因子(VEGF)对其分布的影响。方法20只新西兰大白兔随机分为实验组(VEGF组)和对照组,2组动物常规全麻,气管插管,胸骨正中切开,暴露心脏,结扎左室支建立心肌梗死模型,冠状静脉窦插管,实验组逆行灌注VEGF蛋白,对照组以生理盐水对照。全程记录心电,逆行灌注后30min取梗死区(左室心尖部)及非梗死区(高侧壁)心肌检测VEGF蛋白分布情况。结果结扎左室支即刻所有动物出现ST段抬高并与T波融合,免疫组织化学显示实验组梗死区有大量的VEGF蛋白,Western blot分析显示实验组梗死区在22kd处有明显的阳性条带,而非梗死区及对照组则为阴性。结论冠状静脉窦逆行灌注技术能很好地将VEGF蛋白靶向导入梗死区。 Objective To observe the distribution of vascular endothelial growth factor (VEGF) by coronary sinus retrograde perfusion in rabbit myocardial infarction model. Methods Twenty Newzland rabbits were divided into 2 groups, general anesthesia and open thorax, elevating the apex of the heart, and clamping the main stem of left ventricular coronary. VEGF165 were retrograde perfused trough coronary sinus in experiment group, and nature saline were used in control group. The distribution of VEGF165 were tested at different points of the left ventricle. Results ST segment elevated immediately and pathologic Q wave appeared 30min after the ligation of the left main ventricular branch. Comparing with control group, more VEGF protein were observed in experiment group and there's positive land at 22kd by Western blot in experiment group. Conclusion Retrograde coronary sinus perfusion technique could perfectly distribute VEGF protein to the target lschemia area in rabbit myocardial infarction model.
出处 《贵州医药》 CAS 2008年第6期499-500,共2页 Guizhou Medical Journal
基金 贵州省科技厅黔科合计[2004]3065 省长资金:黔省专[2005]33号资助项目
关键词 冠状静脉窦逆行灌注 血管内皮生长因子 心肌梗死 Coronary sinus retrograde perfusion VEGF Rabbit Myocardial infarction
  • 相关文献

参考文献6

  • 1Castilla MA,Caramelo C,Gazapo RM, et al. Role of endothelial growth factor(VEGF) in endothelial cell protection against cytotocic agents [J]. Life Sciences, 2000,67:1 003-1 013.
  • 2Lopez J J, Lahan RF, Stamler A, et al. VEGF administration in chronic myocardial ischemia in pigs[J]. Cardiovasc Res, 1998,40(2) :272-281.
  • 3Mack CA,Pales ST, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 inproves myocardial peffusion and function in the ischemic porcine heart [J]. J Thorac Cardiovasc Surg, 1998,115(1) : 168-176.
  • 4[美]J 萨姆布克,EF 弗里鲁奇,T 曼尼阿蒂斯著.金冬雁等译.分子克隆实验指南[M].科学出版社,1993:362.
  • 5Yamagishi S, Yinekura H, Yamamoto Y, et al. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditionUJ] . Lab Invest, 1999,79 (4) : 501-509.
  • 6Ryden L, Tadokoro H, Sjoquist FO, et al. Pronounced accumulation of metoprolol in ischemic myocardium after coronary venous retroinfusion [J]. J Cardiovasc Pharacol, 1990,15 : 22.

同被引文献25

  • 1HOCHMAN J S, LAMAS G A, BULLER C E, et al. Coronary intervention for persistent occlusion after myocardial infarction[J]. N Engl J Med, 2006, 355(23) : 2395-2407.
  • 2FONAROW G C, WRIGHT R S, SPENCER F A, et al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality [ J ]. Am J Cardiol, 2005, 96(5): 611-616.
  • 3MATSUNAGA T, WARLTIER D C, WEIHRAUNCH D W, et al. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide[J]. Circulation, 2000, 102(25) : 3098-3103.
  • 4SATO K, WU T, LAHAM R J, et al. Efficacy of intracoronary or intravenous VEGF 165 in a pig model of chronic myocardial ischemia[J]. JACC, 2001, 37(2): 616-623.
  • 5ROOPRAI H K, RUCKLIDGE G J, PANOU C, et al. The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumor cells [J]. Br J Cancer, 2000, 82(1) : 52-55.
  • 6KATRA R P, LAURITA K R. Cellular mechanism of calcium- mediated triggered activity in the heart [J]. Circ Res, 2005, 96(5) : 535-542.
  • 7ANDERSON K P. Lipid-lowering therapy for prevention of ventrieular taehyarrhythmias[J]. J Am Coil Cardiol, 2003, 42 (1):88-92.
  • 8SHIROSHITA-TAKESHITA A, SCHRAM G, LAVOIE J, et al. Effect of simvastatin and antioxidant vitamins on atrial fibrellation promotion by atri-al-tachycardia remodeling in dogs [J]. Circulation, 2004, 110(16) : 2313-2319.
  • 9TAMARGO J, CABALLER, GOMEZ R, et al. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy[J]. Pharmacol Ther, 2007, 114(1): 107-126.
  • 10Kelkar AA,Butler J,Schelbert EB,et al.Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy:Possible Modulating Effects of Paracrine Activities of Stem Cells[J].J Am Coll Cardiol,2015,66(18):2038-2047.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部